一键升级您的黄金投资账户！顶尖投资者这么布局黄金赛道>> 【头条要闻】 中方回应第六轮中美经贸磋商 商务部2月26日举行例行发布会。商务部新闻发言人何咏前在回应近期将举行的第六轮中美经贸磋商相 关提问时表示，中美双方通过中美经贸磋商机制，在各层级持续保持沟通。中方愿与美方一道，共同落 实好、维护好两国元首釜山会晤和2月4日通话共识，通过平等协商，妥善管控分歧，拓展务实合作，维 护中美经贸关系健康、稳定、可持续发展，更好造福两国，惠及世界。 德国总理默茨访华，中德经贸达成哪些成果？商务部：已达成十余项商业协议 2月26日，商务部召开例行新闻发布会。对于春节消费特点、德国总理访华等热点话题，商务部新闻发 言人分别进行了回应。 德国总理默茨本周正在中国访问，请问在经贸领域双方达成了哪些具体成果？商务部如何看待中德经贸 合作前景？ 对此，商务部新闻发言人何咏前表示，2月25日至26日，德国总理默茨率高规格经济代表团访华，中德 双方在经贸领域开展了深入交流，取得了积极务实成果。习近平主席在会见默茨总理时指出，中德双方 要做开放互利的创新伙伴，双方应加强发展战略对接，促进人工智能等前沿领域对话合作。这为进一步 深化中德经 ...

作者 |第一财经 钱童心 2月25日亚太股市开盘后，联邦制药（3933.HK）股价一路上涨，下午股价一度飙涨超过7%。 前一日，联邦制药公布了新一代三重靶点减重药UBT251中国的一项中期临床试验数据，该注射液每周 给药一次，在连续给药24周后，试验药组平均减重达19.7%，安慰剂组仅为2%。 2026.02.25 本文字数：1021，阅读时长大约2分钟 在减重药竞争日益加剧的背景下，跨国制药巨头纷纷聚焦中国的减重药资产。就在2月24日，中国减重 药开发商先为达生物宣布与辉瑞中国达成战略合作，辉瑞将获得其核心GLP-1类产品埃诺格鲁肽注射液 在中国大陆的独家商业化权益。这项合作总交易额最高可达近5亿美元。 去年12月，辉瑞还与复星医药控股子公司药友制药达成许可协议，获得一款口服小分子GLP-1受体激动 剂的全球独家权益，交易总额超过20亿美元。 去年7月，石药集团以20.75亿美元将口服小分子GLP-1受体激动剂授权给Madrigal公司；今年年初，石 药集团又将另一款双靶点的新一代减重注射药授权给阿斯利康。 目前，包括恒瑞医药、翰森制药、诚益生物在内的本土药企的GLP-1类药物都已经通过对外授权的方式 实现 ...

2月20日，激光雷达"第一股"速腾聚创（02498.HK）股价盘中一度涨超15%。截至南都湾财社记者发稿，速腾聚创 股价涨幅达9.59%，报收37.70港元/股，总市值达182亿港元。 消息面上，19日晚，速腾聚创发布正面盈利预告，公司预计2025年第四季度首次实现单季度盈利，盈利规模不低 于6000万元，大幅超出管理层此前盈亏平衡预期。同时，2025年全年净亏损同比显著收窄。这意味着港股激光雷 达"第一股"正式告别持续亏损阶段。 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責 · 對其準確性或完整性亦不發 表任何聲明,並明確表示,概不對因本公告全部或任何部份內容而產生或因倚親該等內容而引致的任何損失承 擔任何責任。 rcbosense ROBOSENSE TECHNOLOGY CO., LTD 速 騰 聚 創 科 技 有 限 公 司 (於開曼群島註冊成立的有限公司) (股份代號:2498) 盈利預告 本公告乃由速騰聚創科技有限公司(「本公司」,連同其附屬公司统稱「本集團」)根據香港聯合 交易所有限公司證券上市規則(「上市規則」第13.09(2)(a)條及香港法例第571章證券及期貨條 ...

（文章来源：每日经济新闻） 每经AI快讯，2月19日，雀巢公司公布业绩并计划出售冰淇淋业务后，股价延续涨势，目前上涨3.7%， 有望创下自10月以来的最佳单日表现。 ...

Core Viewpoint - Halliburton (HAL.US) has shown significant financial performance and market activity, with a focus on its latest earnings report and business outlook [1]. Financial Performance - On January 21, 2026, Halliburton reported a net profit of $589 million for Q4 2025, with adjusted earnings per share of $0.69, exceeding market expectations of $0.55 [1]. - Total revenue reached $5.66 billion, with international revenue increasing by 7% to $3.5 billion quarter-over-quarter [1]. - Operating cash flow was $1.17 billion, and the company repurchased $250 million of its common stock [1]. Stock Performance - On February 4, 2026, Halliburton's trading volume reached $599 million, a 61.15% increase from the previous day, with a stock price of $34.34, reflecting a daily increase of 1.39% [1]. - Year-to-date, the stock price has risen by 21.51%, and over the past 52 weeks, it has increased by 30.37%, indicating heightened short-term market interest [1]. Market Outlook - On January 22, 2026, Halliburton forecasted that international revenue would remain flat or see slight growth, while North American revenue is expected to decline by a high single-digit percentage [1]. - Total revenue growth for 2025 was approximately 4% [1]. - Institutions such as JPMorgan (target price of $35) and RBC Capital Markets (target price of $38) have recently issued ratings, highlighting potential opportunities in the Venezuelan market and the impact of weak demand in North America [1]. Business Developments - In Q4, Halliburton signed an agreement with Volta Grid to develop distributed generation solutions for data centers, planning to deliver a 400 MW project by 2028 [2]. - The company also secured a comprehensive drilling services contract with Shell in Nigeria, strengthening its position in the energy services sector [2].

Core Viewpoint - The company has experienced a slight increase in shareholder numbers and net capital inflow, with stock performance slightly outperforming its industry sector [1][2]. Recent Events - As of February 10, 2026, the total number of shareholders for the company reached 7,927, an increase of 8 shareholders, representing a growth of 0.10%. The average market value per shareholder rose to 725,100 yuan. On February 11, the company reported a net capital inflow of 5.64 million yuan, accounting for 12.07% of the total trading volume, with the stock price increasing by 0.38% on that day. Additionally, the financing balance reached 226 million yuan on February 12, with a financing purchase amount of 11.91 million yuan, indicating an increase in market activity [2]. Stock Performance - Over the past 7 days, the company's stock price has increased by 1.68%, with a high of 29.16 yuan and a low of 28.49 yuan, resulting in a price fluctuation of 2.35%. The latest closing price on February 13 was 29.04 yuan, with a single-day increase of 0.41% and a trading volume of 6.81 million yuan, leading to a turnover rate of 0.12%. During the same period, the overall pharmaceutical and biological sector experienced a slight decline of 0.18%, while the chemical pharmaceutical sector rose by 0.07%, indicating the company's performance was slightly better than its industry [3]. Financial Report Analysis - According to the company's Q3 2025 report, the revenue for the first three quarters was 704 million yuan, reflecting a year-on-year growth of 9.52%. The net profit attributable to shareholders was 197 million yuan, with a year-on-year increase of 12.8%. However, the non-recurring net profit for Q3 alone was 46.81 million yuan, showing a year-on-year decline of 7.98%, which raises concerns about the sustainability of profitability. The gross margin remained high at 89.69%, and the debt ratio was 10.22%, indicating a relatively stable financial structure [4]. Institutional Viewpoints - According to Guosen Securities' investment strategy for the pharmaceutical and biological industry in February 2026, the valuation of the medical services and consumer sectors is at historical lows, with expectations for fundamental recovery in 2026. The report suggests focusing on undervalued stocks with improving performance. Although the report does not directly mention the company, it highlights opportunities within the chemical pharmaceutical sector, which is relevant to the company's main business [5].

Stock Performance - On February 4, 2026, Carrier Global's trading volume reached $890 million, a significant increase of 57.91% compared to the previous trading day, with the stock price rising by 3.84% to $63.55 [2] - Over the past five trading days, the stock has increased by 9.74%, and year-to-date, it has risen by 20.27%, although it has decreased by 0.52% over the past 52 weeks [2] - The sudden increase in trading activity may reflect a market reassessment of the company's recent developments [2] Recent Events - On December 19, 2025, Carrier Global announced the signing of an agreement to sell its Riello business to Ariston Group, with expected total proceeds of approximately $430 million [3] - The transaction is planned to be completed in the first half of 2026, pending regulatory approvals and customary closing conditions [3] - The company stated that the net proceeds will be used for general corporate purposes, including share repurchases [3] Financial Performance - According to the Q3 2025 financial report released on October 28, 2025, the company's revenue for the period from January to September 2025 was $16.91 billion, a year-on-year decrease of 2.47%, while net profit was $1.525 billion, down 51.42% year-on-year [4] - However, in the first quarter of 2025, the company achieved a year-on-year net profit growth of 51.21%, reaching $437 million [4] - Market attention has shifted to whether the upcoming full-year financial report for 2025 will continue the volatility observed between quarters [4] Strategic Initiatives - During the Q3 2025 earnings call, management mentioned challenges such as weak North American residential business, leading to the announcement of a reduction of 3,000 indirect positions [5] - The board has approved a $5 billion share repurchase authorization as part of efforts to optimize operational efficiency and support long-term growth directions, such as data centers and heat pump businesses [5]

Core Insights - The stock price of Zhipu has surged over 70% in four days, reaching a market capitalization of over 170 billion HKD, three times its IPO valuation [1] - Zhipu's new generation base model GLM-5 was officially launched on February 12, continuing the upward trend in stock price [1] - The rapid increase in stock value has created significant wealth for employees, with many becoming millionaires due to their shareholdings [1][3] Company Background - Zhipu was founded in 2019, building on research from Tsinghua University's KEG laboratory, which started in 2006 [2] - The company went public on the Hong Kong Stock Exchange in January 2023, becoming the "first global large model stock" with an initial market cap exceeding 50 billion HKD [2] - Over 50 institutional investors backed Zhipu prior to its IPO, including major venture capital firms and tech giants like Alibaba and Tencent [2] Employee Wealth Creation - As of June 2025, Zhipu has 883 employees, with 452 holding shares, representing 51.2% of the workforce [3] - The employee stock ownership platforms, Huihui and Zhiden, were established in 2021, with significant stakes held by employees and executives [3] - The average share value for employees is estimated to exceed 14 million HKD, with some employees holding shares worth up to 200 million HKD [3] Market Dynamics - The surge in Zhipu's market value is attributed to the launch of the GLM-5 model, which has shown superior performance in programming and agent capabilities [4] - The AI sector in Haidian has seen a wave of successful IPOs, including companies like Moore Threads, which also experienced rapid stock price increases [5] - Haidian is becoming a hub for AI innovation, with a significant number of AI companies and talent concentrated in the area [8][9] Industry Growth - The AI market in Haidian is projected to reach 360 billion RMB by 2025, with over 1,900 core AI enterprises established [8] - Haidian has a strong ecosystem for AI development, including numerous research institutions and a high concentration of top AI talent [9][10] - The local government has actively supported AI companies through funding and investment initiatives, fostering a conducive environment for growth [10]

每经编辑｜陈柯名 据参考消息援引新加坡《联合早报》网站1月21日报道，美国总统特朗普在世界经济论坛2026年年会发表讲话时，突然即兴调侃法国总统马克龙的"漂亮墨 镜"，并好奇追问其佩戴缘由。特朗普提及戴着墨镜出席年会的马克龙时，问道："到底发生了什么？" 据报道，马克龙20日在达沃斯登台时，佩戴着一副蓝色镜面飞行员款式的墨镜。马克龙戴墨镜讲话的视频和图片在网络上走红后，他佩戴的墨镜品牌所属 集团股价在22日也一度上涨了近28%。 据悉，马克龙佩戴的墨镜来自法国高端小众品牌Henry Jullien。该品牌曾濒临破产，后被意大利眼镜公司iVision Tech收购。iVision Tech21日透露，马克龙 佩戴的眼镜型号为 Pacific S 01，在其网站上的售价为659欧元（约合人民币5399元）。 ▲马克龙同款墨镜售价659欧元 ▲法国总统马克龙戴着一副飞行员墨镜亮相演讲台 图源：红星新闻 有网友称，当马克龙戴着墨镜出场时，不免让人联想到美国知名演员汤姆·克鲁斯在电影《壮志凌云》中扮演的桀骜不驯的飞行员。不少人猜测，马克龙 这种造型是否在暗示他不会就格陵兰岛问题向特朗普屈服。也有人认为，他可能是在暗讽特 ...

Core Insights - Costco's sales are experiencing significant growth, with net sales increasing by 8.5% year over year to $29.86 billion for the five weeks ending January 4 [2] - The company's stock price rose over 3% following the release of its December sales figures, reflecting positive market sentiment [1] Sales Performance - Comparable sales in the U.S. grew by 6.3%, while companywide comparable sales increased by 6.2%, excluding the effects of gasoline price fluctuations and foreign exchange rates [2] - Digitally enabled sales surged by 18.3%, indicating strong performance in Costco's online retail segment [4] Market Position - Costco's strategy of offering quality merchandise at low prices is resonating well with consumers, particularly in a cash-strapped environment [4] - The company's large scale allows it to provide a curated selection of goods at competitive prices, making it difficult for rivals to match [4] Customer Loyalty and Growth Strategy - The savings provided by Costco help build loyalty among its members, driving repeat traffic and stable profits [5] - Expansion of store count, along with growing sales at existing locations, is expected to continue fueling Costco's earnings growth in the future [5]